CAL 54, a new cell line derived from a human renal carcinoma: Characterization and radiosensitivity;CAL 54, une nouvelle lignee cellulaire derivee d'un carcinome renal humain: Caracterisation et radiosensibilite

Bulletin du Cancer

Volumn 83, Issue 7, 1996, Pages 553-558

  Gioanni, J ^a,b   Zanghellini, E ^a   Mazeau, C ^a   Amiel, J ^c   Poustis Delpont, C ^d   Lagrange, J L ^a   Duplay, H ^a   Caldani, C ^a   Courdi, A ^a  

^a CENTRE ANTOINE LACASSAGNE   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

^c PASTEUR HOSPITAL   (France)

^d CENTRE DE BIOCHIMIE   (France)

Author keywords

human cell line; immunostaining; radiosensitivity; renal carcinoma

Indexed keywords

CYTOKERATIN; EPITHELIAL MEMBRANE ANTIGEN; VIMENTIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; COLONY FORMATION; DIPLOIDY; DNA CONTENT; FLOW CYTOMETRY; HISTOLOGY; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MOUSE; NONHUMAN; NUDE MOUSE; PLEURA EFFUSION; RADIATION RESPONSE; RADIOSENSITIVITY; STATISTICAL MODEL; AGED; ANIMAL; CASE REPORT; CELL CULTURE; CELL DIVISION; CELL LINE; IMMUNOLOGY; KIDNEY TUMOR; MALE; METASTASIS; PATHOLOGY; PLEURA TUMOR; RADIATION EXPOSURE;

AGED; ANIMALS; CARCINOMA, RENAL CELL; CELL DIVISION; CELL LINE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FLOW CYTOMETRY; HUMANS; KIDNEY NEOPLASMS; MALE; MICE; MICE, NUDE; PLEURAL NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0030185979     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Anglard P, Trahan E, Liu, Latif F et al. Molecular and cellular characterization of human renal cell carcinoma cell line. Cancer Res 1992;52:348-56
2. Bear A, Clayman R, Elbers J et al. Characterization of two human cell lines (TK-10, TK-164) of renal cell cancer. Cancer Res 1987;47:3856-62
3. Beniers A, Peelen W, Schaafsma H et al. Establishment and characterization of five new human renal tumor xenografts. Am J Pathol 1992;140:483-95
4. Buszello H, Ackermann R. Establishment and characterization of two new human renal cancer cell lines (DNT-11 and DNT-63) derived from metastases. Anticancer Res 1994; 4:173-6
5. Courdi A, Bensadoun R, Gioanni J et al. Inherent radiosensitivity and split-dose recovery in plateau-phase cultures of 10 human tumor cell lines. Radiother Oncol 1992;24:102-7
6. Deacon J, Peckham M, Steel G. The radioresponsiveness of human tumours and the initial slope of the cell survival curve. Radiother Oncol 1984;2:317-23
7. Droz D, Zachar D, Charbit L et al. Expression of the human nephron differentiation molecules in renal cell carcinomas. Am J Pathol 1990;137:895-903
8. Fertil B, Dertinger H, Courdi A et al. Mean inactivation dose: a useful concept for intercomparison of human cell survival curves. Radiat Res 1984;99:73-84
9. Fertil B, Malaise E. Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors; analysis of 101 published survival curves. Int J Radiat Oncol Biol Phys 1985;11:1699-707
10. Finney R. An evaluation of postoperative radiotherapy in hypernephroma treatment - A clinical trial. Cancer 1973; 32:1332-40
11. Grossman H, Wedemeyer G, Ren L. Human renal carcinoma: characterization of five new cell lines. J Surg Oncol 1985;28:237-44
12. Gumerlock P, Edwards B, Deitch A et al. Human renal clear cell carcinoma: establishment and characterization of a new cell line (G-2101). In Vitro Cell Dev Biol 1988;24: 429-34
13. Gunther A, Kinjo M, Winter H et al. Differential expression of intermediate-filament proteins in murine sarcoma 180 ascites or solid tumor. Cancer Res 1984;44:2590-4
14. Hashimura T, Tubbs R, Connelly R et al. Characterization of two cell lines with distinct phenotypes and genotypes established from a patient with renal cell carcinoma. Cancer Res 1989;49:7064-71
15. Kjaer M, Iversen P, Hvidt V et al. A randomized trial of postoperative radiotherapy versus observation in Stage II and III renal adenocarcinoma. Scand J Urol Nephrol 1987; 21:285-9
16. Leung S, Mitchell J, Al-Nabulsi I et al. Effect of L-Buthionine Sulfoximine on the radiation response of human renal carcinoma cell lines. Cancer 1993;71:2276-85
17. Lizard G, Roignot P, Dusserre-Guion L et al. Characterization of Seven Kidney Tumors by Flow Cytometry: Analysis of cell cycle, DNA content and P-Glycoprotein expression. Eur Urol 1992;21(Suppl 1):39-42
18. Rafla S. Renal cell carcinoma. Natural history and results of treatment. Cancer 1970;25:26-40
19. Ramaekers F, Haag D, Kant A et al. Coexpression of Keratin- and Vimentin-type intermediate filaments in human metastatic carcinoma cells. Proc Natl Acad Sci USA 1983;80:2618-22
20. Riches EW. The place of radiotherapy in the management of parenchymal carcinoma of the kidney. J Urol 1996;95: 313-7
21. Saiki I, Naito S, Yoneda J et al. Characterization of the invasive and metastatic phenotype in human renal cell carcinoma. Clin Expl Metastasis 1991;9:551-66
22. Scheren E, Wirtz C. The role of postoperative radiotherapy in the treatment of hypernephroid carcinoma. Strahlenther Onkol 1988;164:371-85
23. Stein M, Kuten A, Halpern J et al. The value of postoperative irradiation in renal cell cancer. Radiother Oncol 1992; 24:41-4
24. Van der Werf-Messing B. Carcinoma of the kidney. Cancer 1973;32:1056-61
25. Vindelow L, Christensen I, Nissen N. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983;3:323-7
26. Weichselbaum R, Nove J, Little JB. X-ray sensitivity of human cell in vitro. Int J Radiat Oncol Biol Phys 1980;6: 437-40
27. Yano H, Maruiwa M, Sugihara S et al. Establishment and characterization of a new human renal cell carcinoma cell line (KRC/Y). In Vitro Cell Dev Biol 1988;24:9-16